Home/Filings/4/0001562180-24-001390
4//SEC Filing

Aulick Rodney 4

Accession 0001562180-24-001390

CIK 0001524472other

Filed

Feb 15, 7:00 PM ET

Accepted

Feb 16, 4:36 PM ET

Size

9.1 KB

Accession

0001562180-24-001390

Insider Transaction Report

Form 4
Period: 2024-02-14
Aulick Rodney
EVP & President, WSS
Transactions
  • Exercise/Conversion

    Common Stock

    2024-02-14$43.50/sh+23,870$1,038,345104,365 total
  • Sale

    Common Stock

    2024-02-14$122.55/sh23,870$2,925,15980,495 total
  • Exercise/Conversion

    Non-Qualified Stock Option (Right to Buy)

    2024-02-1423,87023,870 total
    Exercise: $43.50Exp: 2028-04-02Common Stock (23,870 underlying)
Footnotes (2)
  • [F1]This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 23,870 Shares were executed at a range of prices from $122.45 to $123.4499. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.
  • [F2]The April 2, 2018 option grant vested one fourth on January 1, 2019, January 1, 2020, January 1, 2021, and January 1, 2022.

Issuer

Xylem Inc.

CIK 0001524472

Entity typeother

Related Parties

1
  • filerCIK 0001720147

Filing Metadata

Form type
4
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 4:36 PM ET
Size
9.1 KB